Cornavirus Variant
- All
- News
-
Variants Will Keep On Coming, Nothing To Panic About: Covid Panel Head
- Monday April 11, 2022
- India News | Asian News International
New COVID-19 variants will keep coming, however, the new variants aren't causing severe diseases or increasing the number of cases said Chairman of the COVID-19 working group of India said.
- www.ndtv.com
-
India Records Over 90,000 New Covid Cases In 24 Hours
- Thursday January 6, 2022
- India News | Reported by Parimal Kumar, Edited by Arun Nair
India reported 90,928 fresh COVID-19 cases in the last 24 hours, 56 per cent higher than yesterday's 58,097 cases. The country has 2,630 cases of the Omicron variant - the most in Maharashtra with 797 cases, followed by Delhi with 465 cases.
- www.ndtv.com
-
India Covid Latest News LIVE Updates: India Sees Fewest Covid Cases In 75 Days; 2,726 Deaths
- Tuesday June 15, 2021
- India News | NDTV
Novavax's COVID-19 vaccine is more than 90 per cent effective, including against coronavirus variants, the vaccine maker said Monday after a large-scale US study.
- www.ndtv.com
-
Variants Will Keep On Coming, Nothing To Panic About: Covid Panel Head
- Monday April 11, 2022
- India News | Asian News International
New COVID-19 variants will keep coming, however, the new variants aren't causing severe diseases or increasing the number of cases said Chairman of the COVID-19 working group of India said.
- www.ndtv.com
-
India Records Over 90,000 New Covid Cases In 24 Hours
- Thursday January 6, 2022
- India News | Reported by Parimal Kumar, Edited by Arun Nair
India reported 90,928 fresh COVID-19 cases in the last 24 hours, 56 per cent higher than yesterday's 58,097 cases. The country has 2,630 cases of the Omicron variant - the most in Maharashtra with 797 cases, followed by Delhi with 465 cases.
- www.ndtv.com
-
India Covid Latest News LIVE Updates: India Sees Fewest Covid Cases In 75 Days; 2,726 Deaths
- Tuesday June 15, 2021
- India News | NDTV
Novavax's COVID-19 vaccine is more than 90 per cent effective, including against coronavirus variants, the vaccine maker said Monday after a large-scale US study.
- www.ndtv.com